A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
Author(s) -
Miquel Bioque,
Adrián LLerena,
Bibiana Cabrera,
Gisela Mezquida,
António Lobo,
Ana GonzálezPinto,
Covadonga M. DíazCaneja,
Iluminada Corripio,
Eduardo J. Aguilar,
Antoni Bulbena,
Josefina CastroFornieles,
Eduard Vieta,
Amàlia Lafuente,
Sergi Mas,
Mara Parellada,
Jerónimo SaizRuiz,
Manuel J. Cuesta,
Miquel Bernardo
Publication year - 2015
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyv121
Subject(s) - pharmacovigilance , antipsychotic , medicine , psychosis , clozapine , psychiatry , guideline , medical prescription , adverse effect , aripiprazole , psychology , schizophrenia (object oriented programming) , drug , pharmacology , pathology
The characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of first episode of psychosis attended in daily practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom